MAJI Nextel Medical Corp.
Communications Services, NEC · OTC · SEC CIK 1492448 · Fiscal year ends 12/31
Financial factors as of 2020-07-31 (2021Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-460.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-103,659.0%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets46,425.3%
Debt / equity—
Current ratio0.00x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.22x
Accruals ratio-80,708.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2021Q12020-07-31 | 2020Q4*2020-04-30 | 2020Q32020-01-31 | 2020Q22019-10-31 | 2020Q12019-07-31 | 2019Q4*2019-04-30 | 2019Q32019-01-31 | 2019Q22018-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | — | — | — | — | — | — | — | $0 |
| Gross profit | — | — | — | — | — | — | — | $0 |
| SG&A expense | $62,917 | $167,384 | $242,917 | $30,783 | $26,778 | $43,204 | $26,779 | $28,088 |
| Operating income | -$62,917 | -$167,384 | -$242,917 | -$30,783 | -$26,778 | -$43,204 | -$26,779 | -$28,088 |
| Pretax income | — | -$167,853 | -$242,917 | -$30,783 | — | -$43,204 | -$26,779 | -$28,088 |
| Income tax | — | $0 | $0 | $0 | — | $0 | $0 | $0 |
| Net income | -$76,742 | -$167,853 | -$242,917 | -$30,783 | $5,603 | -$43,204 | -$26,779 | -$28,088 |
| EPS (basic) | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 249.84M | — | 249.82M | 249.78M | 249.78M | — | 249.78M | 249.78M |
| Balance sheet | ||||||||
| Cash & equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $25 | $14 |
| Current assets | $1,000 | $58,265 | $0 | $0 | $0 | $0 | $25 | $14 |
| Total assets | $1,000 | $58,265 | $0 | $0 | $0 | $0 | $25 | $14 |
| Current liabilities | $464,253 | $444,776 | $218,658 | $41,740 | $10,957 | $214,286 | $171,107 | $144,317 |
| Total liabilities | $464,253 | $444,776 | $218,658 | $41,740 | $10,957 | $214,286 | $171,107 | $144,317 |
| Shareholders' equity | -$463,253 | -$386,511 | -$218,658 | -$41,740 | -$10,957 | -$214,286 | -$171,082 | -$144,303 |
| Shares outstanding | 249.84M | 249.84M | 249.84M | 249.78M | 249.78M | 249.78M | 249.78M | 249.78M |
| Cash flow statement | ||||||||
| Operating cash flow | -$61,321 | $56,650 | -$84,459 | -$25,622 | -$116,300 | -$1,603 | -$6,119 | -$324 |
| Investing cash flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing cash flow | $61,321 | -$56,650 | $84,459 | $25,622 | $116,300 | $1,578 | $6,130 | $0 |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.